NxStage Voluntary Sak Recall
Higher levels of endotoxin than NxStage tolerates were found in less than 1% of affected sak lots, so they notified patients who had those lots and issued a voluntary recall. An FDA recall was not required.
Read the full article » | Posted 02-15-2018
Related Articles
- Vantive: Real People, Real Stories on PD Empowers Site for Patients Posted 12-17-2025
- Medicare Fee Schedule Final Rule Summary: CY 2026 Posted 12-17-2025
- Medicare Deductible, Coinsurance & Premium Rates for 2026 Posted 12-17-2025
- Watch Dr. Joel Glickman’s ASN presentation on Home HD Prescriptions Posted 12-17-2025

